206 related articles for article (PubMed ID: 34109661)
1. The use of mass spectrometry in a proteome-centered multiomics study of human pituitary adenomas.
Li N; Desiderio DM; Zhan X
Mass Spectrom Rev; 2022 Nov; 41(6):964-1013. PubMed ID: 34109661
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas.
Li J; Zhan X
Biochim Biophys Acta Proteins Proteom; 2021 Mar; 1869(3):140584. PubMed ID: 33321259
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives.
Zhan X; Desiderio DM
Mass Spectrom Rev; 2005; 24(6):783-813. PubMed ID: 15495141
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.
Zhan X; Wang X; Long Y; Desiderio DM
BMC Med Genomics; 2014 Dec; 7():69. PubMed ID: 25539738
[TBL] [Abstract][Full Text] [Related]
5. Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome.
Zhan X; Huang Y; Long Y
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29658936
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in proteomics and its implications in pituitary endocrine disorders.
Banerjee A; Goel A; Shah A; Srivastava S
Biochim Biophys Acta Proteins Proteom; 2021 Nov; 1869(11):140700. PubMed ID: 34303023
[TBL] [Abstract][Full Text] [Related]
7. Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.
Zhan X; Wang X; Cheng T
Front Endocrinol (Lausanne); 2016; 7():54. PubMed ID: 27303365
[TBL] [Abstract][Full Text] [Related]
8. The human pituitary proteome: the characterization of differentially expressed proteins in an adenoma compared to a control.
Desiderio DM; Zhan X
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):689-712. PubMed ID: 14528906
[TBL] [Abstract][Full Text] [Related]
9. Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.
Yu SY; Hong LC; Feng J; Wu YT; Zhang YZ
Tumour Biol; 2016 Jul; 37(7):8923-30. PubMed ID: 26753958
[TBL] [Abstract][Full Text] [Related]
10. Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
Chen Y; Gao H; Xie W; Guo J; Fang Q; Zhao P; Liu C; Zhu H; Wang Z; Wang J; Gui S; Zhang Y; Li C
Aging (Albany NY); 2020 Dec; 13(1):1276-1293. PubMed ID: 33472173
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenoma nitroproteomics: current status and perspectives.
Zhan X; Wang X; Desiderio DM
Oxid Med Cell Longev; 2013; 2013():580710. PubMed ID: 23533694
[TBL] [Abstract][Full Text] [Related]
12. Proteomic and Transcriptomic Analysis Identify Spliceosome as a Significant Component of the Molecular Machinery in the Pituitary Tumors Derived from
Taniguchi-Ponciano K; Peña-Martínez E; Silva-Román G; Vela-Patiño S; Guzman-Ortiz AL; Quezada H; Gomez-Apo E; Chavez-Macias L; Mercado-Medrez S; Vargas-Ortega G; Espinosa-de-Los-Monteros AL; Gonzales-Virla B; Ferreira-Hermosillo A; Espinosa-Cardenas E; Ramirez-Renteria C; Sosa E; Lopez-Felix B; Guinto G; Marrero-Rodríguez D; Mercado M
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33261069
[TBL] [Abstract][Full Text] [Related]
13. A reference map of a human pituitary adenoma proteome.
Zhan X; Desiderio DM
Proteomics; 2003 May; 3(5):699-713. PubMed ID: 12748949
[TBL] [Abstract][Full Text] [Related]
14. Integration of Proteomics and Metabolomics Revealed Metabolite-Protein Networks in ACTH-Secreting Pituitary Adenoma.
Feng J; Zhang Q; Zhou Y; Yu S; Hong L; Zhao S; Yang J; Wan H; Xu G; Zhang Y; Li C
Front Endocrinol (Lausanne); 2018; 9():678. PubMed ID: 30532734
[TBL] [Abstract][Full Text] [Related]
15. Pattern recognition for predictive, preventive, and personalized medicine in cancer.
Cheng T; Zhan X
EPMA J; 2017 Mar; 8(1):51-60. PubMed ID: 28620443
[TBL] [Abstract][Full Text] [Related]
16. Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas.
Zhan X; Evans CO; Oyesiku NM; Desiderio DM
Pituitary; 2003; 6(4):189-202. PubMed ID: 15237930
[TBL] [Abstract][Full Text] [Related]
17. Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas.
Long Y; Lu M; Cheng T; Zhan X; Zhan X
Front Endocrinol (Lausanne); 2019; 10():835. PubMed ID: 31920959
[TBL] [Abstract][Full Text] [Related]
18. Molecular Biology of Pituitary Adenomas.
Faltermeier CM; Magill ST; Blevins LS; Aghi MK
Neurosurg Clin N Am; 2019 Oct; 30(4):391-400. PubMed ID: 31471046
[TBL] [Abstract][Full Text] [Related]
19. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.
Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G
Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319
[TBL] [Abstract][Full Text] [Related]
20. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
